MediJean Launches Canadian National Debate On Medical Marijuana
TORONTO, Oct. 18, 2013 /CNW/ - MediJean is pleased to announce that starting today it will be hosting a month-long online debate on the subject of medical marijuana. The Medical Marijuana Debates will invite the public, patients, doctors, law enforcement personnel, and politicians to take part by exchanging their comments, views, and experiences with this important medicine.
"As a leader in this new industry, we felt it was important to host a national debate in order to raise awareness around medical marijuana," said Anton Mattadeen, chief strategy officer at MediJean. "Our goal with this debate is to spur conversation around medical marijuana and bring key issues and public input onto a national stage at a scale that has never been done."
The medical marijuana industry needs informed voices as it develops. Mattadeen says this is why MediJean is going to great efforts to host programs such as the Medical Marijuana Debates that will provide the public, patients, medical professionals and other stakeholders with industry-leading resources that cannot be found anywhere else.
Health Canada announced in June new regulations that will change the way Canadians access marijuana for medical purposes. These regulations require patients who need medical marijuana to receive a prescription from a doctor or nurse practitioner and have their medicine shipped directly to them from a Health Canada approved Licensed Producer."As Canada is transitioning into the new regulations, it's important to move the dialogue around medical marijuana to a point where we can have an honest and fact-based discussion," said Mattadeen. "MediJean is committed to providing doctors, patients and the public with information they can use to explore the topic, become aware of the various viewpoints and ultimately make more informed decisions on medical marijuana." The debate will take place in an online forum, where the public, doctors, nurse practitioners and other industry stakeholders will weigh-in on discussions about medical marijuana.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts